We implanted 2 × 106 GRPR+ (PC3, group 1 and group 2) and GRPR− (DU145, group 3 and group 4) prostate cancer cells subcutaneously to the right flanks of male nu/nu mice (N = 5 for each group). The gene discussed is GRPR; the disease is prostate carcinoma.